AMILI – Advancing Human
Health Through A Healthy
Gut and Microbiome Science

As part of Dr. Ong’s work in gastroenterological research and development, he co-founded AMiLi, Southeast Asia’s first and only precision gut microbiome company and stool bank, serving as a hub for healthy gut microbiome innovation and therapy. AMiLi’s goal is to advance microbiome research, grounded in science and compassion, to address unmet and critical needs in healthcare with the potential to positively impact millions of lives across Asia, empowering people with the benefits of a healthy gut. Read more about AMiLi here. READ MORE